Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: Prevalence, titre, and IgG subclass

Gut

Volumn 38, Issue 3, 1996, Pages 384-389

  Bansi, D S ^a,b   Fleming, K A ^a   Chapman, R W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antineutrophil cytoplasmic antibodies; IgG subclass; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

GRANULOCYTE ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0029864461     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.3.384     Document Type: Article

References (25)

1. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385-91.
2. Duerr RH, Targan SR, Landers CJ, Sutherland SR, Shanahan F. Antineutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/ diarrhoeal illnesses. Gastroenterology 1991; 100: 1590-6.
3. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33: 657-62.
4. Lo SK, Fleming KA, Chapman RW. Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992; 33: 1370-5.
5. Chapman RW, Arborgh BM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870-7.
6. Saxon A, Shanahan F, Lander C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibody is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202-10.
7. Oudkerk Pool MO, Ellerbroek PM, Meuwissen SGM. Serum antineutrophil autoantibodies in inflammatory bowel disease; localisation studies of the related antigen(s). Gastroenterology 1991; 100 (5): A236.
8. Mecarelli LH, Nusbaum P, Noel LH. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992; 90: 79-84.
9. Ellerbroek PM, Oudkerk Pool M, Ridwan BU, Dolman KM, Von Blomberg BME, Kr von dem Borne AEG, et al. Neutrophil cytoplasmic antibodies (pANCA) in ulcerative colitis. J Clin Pathol 1994; 47: 257-62.
10. Peen E, Almer S, Bodemar B, Ryden BO, Sjolin T, Tejle K, Skogh T. Antilactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn's disease. Gut 1993; 34: 56-62.
11. Nassberger L, Ljungh A, Schumacher G, Kollberg B. Beta-glucoronidase antibodies in ulcerative colitis [Letter]. Lancet 1992; 340: 734-5.
12. Kaneko K, Suzuki Y, Yamashiro Y, Yabuta K. Is pANCA in ulcerative colitis directed against beta-glucoronidase? Lancet 1993; 341: 320.
13. Vidrich A, Lander C, Sandborn B, Wiesner RH, Lindor KD, Targan SR. IgG subclass distinguishes between PSC and UC ANCA. Gastroenterology 1993; 104: A1015.
14. Schur PH. IgG subclasses - a review. Ann Allergy 1987; 58: 89-95.
15. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report of a therapeutic trial. BMJ 1955; 2: 1041-8.
16. Pokorny CS, Norton ID, McCaughan GW, Selby W. Antineutrophil cytoplasmic antibody: A prognostic indicator in primary sclerosing cholangitis. Journal of Gastroenterology and Hepatology 1994; 9: 40-4.
17. Lo SK, Chapman RW, Cheeseman P, Charlton CP, Walker-Smith JA, Mieli-Vergani G. Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood? Gut 1993; 34: 199-202.
18. Jayne DRW, Weetman AP, Lockwood CM. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991; 84: 476-81.
19. Rubin RL, Tang FL, Chan EKL, Pollard KM, Tsay G, Tan EM. IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. J Immunol 1986; 137: 2528.
20. Brouwer E, Cohe Tervaert W, Horst G, Huitema MG, Van der Giessen M, Limburg PC, Kallenberg CGM. Predominance of IgG1 and IgG4 subclasses of antineutrophil cytoplasmic antibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991; 83: 379-86.
21. Devulder F, Remaux D, Colombel JP, Cortot A. Antineutrophil cytoplasmic autoantibodies. IgG subclass distribution in sera from patients with inflammatory bowel disease. Gastroenterology 1994; 106 (4): A67.
22. Klein R, Eisenberg J, Weber P, Seibold F, Berg P. Significance and specificity of antibodies to neutrophils detected by western blotting for the serologic diagnosis of primary sclerosing cholangitis. Hepatology 1991; 14: 1147-52.
23. Mulder AL, Horst G, Haagsma E, Limburg P, Kleinbenker J, Kallenberg C. Prevalence and characterisation of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17: 411-7.
24. Falk RJ, Jeanette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-7.
25. Jayne DRW, Heaton A, Evans DB, Lockwood CM. Sequential antineutrophil cytoplasm antibody titres in the management of systemic vasculitis. Nephrol Dial Transplant 1990; 4: A309.